# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA663516 | F | Compound was evaluated for the in vitro cytotoxicity against D238 Med human brain medulloblastoma tumor cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
2. | ALA663517 | F | Glutathione (GSH) Concentrations D 283 MR cell line in Human Medulloblastoma Cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
3. | ALA664737 | F | Glutathione S-Transferase (GST) Activity against D 283 MR cell line in Human Medulloblastoma Cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
4. | ALA664738 | F | The compound was tested for cytotoxicity against D283 MR (human) Glioma cell lines | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
5. | ALA664739 | F | Compound was evaluated for cytotoxicity against human medulloblastoma (D283 Med) cell line | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
6. | ALA664740 | F | Glutathione (GSH) Concentrations D 283 cell line in Human Medulloblastoma Cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA664741 | F | Glutathione S-Transferase (GST) Activity against D283 cell line in Human Medulloblastoma Cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
8. | ALA664742 | F | The compound was tested for cytotoxicity against D283 (human) Glioma cell lines | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
9. | ALA2363167 | F | SANGER: Inhibition of human D-283MED cell growth in a cell viability assay. | Homo sapiens | 137 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
10. | ALA5097031 | F | Antiproliferative activity against human D283 Med cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
11. | ALA5097042 | F | Cytotoxicity against human D283 Med cells assessed as reduction in cell viability incubated for 48 hrs by Cell TiterGlo luminescent assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
12. | ALA5097065 | F | Antiproliferative activity against human D283 Med cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTS assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
13. | ALA5097066 | F | Antitumor activity against human D283 Med cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA5097068 | F | Antitumor activity against human D283 Med cells assessed as inhibition of cell proliferation | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
15. | ALA5097072 | F | Anticancer activity against human D283 Med cells assessed as reduction in cell viability incubated for 72 hrs | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA5164304 | F | Anti-tumor activity against human D283 Med cells xenografted in NSG mouse assessed as reduction in tumor volume at 10 mg/kg, ip measured on day 12 | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
17. | ALA5164305 | F | Anti-tumor activity against human D283 Med cells xenografted in NSG mouse assessed as reduction in tumor size at 10 mg/kg, ip measured on day 12 | Homo sapiens | 1 | organism-based format | Scientific Literature |